The DOI matches its Crossref record; 147 of the 151 references it cites were found in a registry or an index.
Dystonia and parkinsonism
Abstract
Parkinsonism and dystonia may coexist in a number of neurodegenerative, genetic, toxic, and metabolic disorders and as a result of structural lesions in the basal ganglia. Parkinson's disease (PD) and the 'Parkinson-plus' syndromes (PPS) account for the majority of patients with the parkinsonism-dystonia combination. Dystonia, particularly when it involves the foot, may be the presenting sign of PD or PPS and these disorders should be suspected when adults present with isolated foot dystonia. Young age, female gender, and long disease duration are risk factors for PD-related dystonia, but dystonia in patients with PD is usually related to levodopa therapy. The mechanism of dystonia in PD is not well understood and the management is often challenging because levodopa and other dopaminergic agents may either improve or worsen dystonia. Other therapeutic strategies include oral medications (baclofen, anticholinergics and benzodiazepines), local injections of botulinum toxin, intrathecal baclofen, and surgical lesions or high frequency stimulation of the thalamus, globus pallidus, or subthalamus.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“but dystonic symptoms are mostly related to treatment, both medical and surgical (Jankovic and Tintner 2001).”
From The clinical symptoms of Parkinson's disease. (2016) · cites this paper as Jankovic and Tintner 2001
Citations
Cites
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
Diagnostic Criteria for Parkinson Disease
Gelb, D. J., Oliver, E., & Gilman, S. (1999) · Archives of Neurology · doi:10.1001/archneur.56.1.33 · Cited by 2,822
Progressive Supranuclear Palsy
Steele, J. C. (1964) · Archives of Neurology · doi:10.1001/archneur.1964.00460160003001 · Cited by 1,930
CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1
Kawaguchi, Y., Okamoto, T., Taniwaki, M., Aizawa, M., Inoue, M., Katayama, S., Kawakami, H., Nakamura, S., Nishimura, M., Akiguchi, I., et al. (1994) · Nature Genetics · doi:10.1038/ng1194-221 · Cited by 1,753
Association between Early-Onset Parkinson's Disease and Mutations in theParkinGene
Lücking, C. B., Dürr, A., Bonifati, V., Vaughan, J. R., Michele, G. D., Gasser, T., Harhangi, B. S., Meco, G., Denèfle, P., Wood, N. W., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005253422103 · Cited by 1,489
The behavioural and motor consequences of focal lesions of the basal ganglia in man.
Bhatia, K., & Marsden, C. (1994) · Brain : a journal of neurology · doi:10.1093/brain/117.4.859 · Cited by 1,137
Graybiel, A. M. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00593-5 · Cited by 1,051
Pathophysiology of the basal ganglia in Parkinson's disease
Obeso, J. A., Rodríguez-Oroz, M. C., Rodrı́guez, M., Lanciego, J. L., Artieda, J., Gonzalo, N., & Olanow, C. W. (2000) · Trends in Neurosciences · doi:10.1016/s1471-1931(00)00028-8 · Cited by 874
The pathophysiology of primary dystonia
Berardelli, A. (1998) · Brain · doi:10.1093/brain/121.7.1195 · Cited by 832
Parkinson’s Disease and Movement Disorders
Tn, M., & Bhattacharyya, K. (2005) · Jaypee Brothers Medical Publishers (P) Ltd. eBooks · doi:10.5005/jp/books/10587 · Cited by 802
Research works printed but not linked: 4
- Jankovic, 2000, Complications and limitations of drug therapy for movement disorders, 55, 52
- Fahn, 2000, The spectrum of levodopa-induced dyskinesias, Ann Neurol, 47, S52
- Segawa, 1976, Hereditary progressive dystonia with marked duiurnal variation, Adv in Neurology, 14, 215
- Walker, 2000, Intrathecal baclofen for dystonia: benefits and complications during six years of experience, Mov Disord, 15, 1242, 10.1002/1531-8257(200011)15:6<1242::AID-MDS1028>3.0.CO;2-Z · DOI
Cited by
Sorted by citations
The clinical symptoms of Parkinson's disease.
Sveinbjornsdottir, S. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13691 · Cited by 1,410
Motor fluctuations and dyskinesias in Parkinson's disease: Clinical manifestations
Jankovic, J. J. (2005) · Movement Disorders · doi:10.1002/mds.20458 · Cited by 549
Self-citationThe functional neuroanatomy of dystonia
Neychev, V. K., Gross, R. E., Lehéricy, S., Hess, E. J., & Jinnah, H. A. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.01.026 · Cited by 473
Azher, S. N., & Jankovic, J. J. (2005) · Neurology · doi:10.1212/01.wnl.0000171857.09079.9f · Cited by 345
Self-citationAshour, R. R., & Jankovic, J. J. (2006) · Movement Disorders · doi:10.1002/mds.21058 · Cited by 231
Self-citation
Metadata
- Authors
- Jankovic, J., & Tintner, R.
- Affiliations
- Baylor College of Medicine (US)
- Corresponding author
- Jankovic, Joseph
- ORCID
- Jankovic, Joseph
- Venue
- Parkinsonism & Related Disorders
- Publisher
- Elsevier BV
- Published
- 2001-10
- Volume
- 8
- Issue
- 2
- Pages
- 109-121
- ISSN
- 1353-8020 (ISSN-L)
- OpenAlex
- W2113609048
- Cited by
- 135
- References
- 151
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 4 · 2023: 4 · 2022: 4 · 2021: 5 · 2020: 6 · 2019: 6 · 2018: 3 · 2017: 4 · 2016: 7 · 2015: 9 · 2014: 4 · 2013: 7 · 2012: 9
- FWCI
- 0.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Parkinsonism & Related Disorders (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Clinical Neurology › Botulinum Toxin and Related Neurological Disorders
- Keywords
- dystonia, parkinsonism
- MeSH terms
- Antiparkinson Agents, Dystonia, Humans, Levodopa, Syndrome, Parkinsonian Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
